In today’s LSCDS weekly #ScienceNewsfeature we would like to highlight this editorial from FiercePharma:“Tucker Carlson’s off-the-rail insults put pharma advertisers in hot seat”.

In industry, the spotlight is on FDA, as this regulatory organization shuffles management and announces appointment of its next acting chief. Ned Sharpless, M.D., currently the director of the National Cancer Institute.

Lastly, Eli Lillyshared the promising results of phase 3 Cyramza-Tarceva pairing in treatment of metastatic EGFR-mutated non-small cell lung cancer.